Glaucoma and Ocular Surface Disease

Glaucoma and Ocular Surface Disease: More than Meets the Eye

Several studies have shown that ocular surface inflammation secondary to glaucoma medication use intensifies the wound healing response to ...

Impact of glaucoma medications on the ocular surface and how ...

Among patients being treated for glaucoma with IOP-lowering eye drops, the prevalence is reported to increase to as much as 45–60% [4,5]. Although the use of ...

Ocular Surface Disease in Patients with Glaucoma - EyeWiki

Introduction, Disease Entity, Management, Conclusion, References, The Academy uses cookies to analyze performance and provide relevant personalized content.

Ocular Surface Disease and Glaucoma Medications - PubMed Central

Prolonged topical treatment for glaucoma significantly increased ocular surface inflammatory marker expression compared with untreated eyes, specifically IgE ...

Ocular surface disease: a known yet overlooked side effect of topical ...

Ocular surface disease (OSD), a disorder affecting the lacrimal and meibomian glands and the corneal and conjunctival epithelium, is a well-known complication ...

Impact of glaucoma medications on the ocular surface and how ...

Ocular surface disease (OSD) in glaucoma patients is common and frequently unrecognized and untreated. The prevalence of OSD in glaucoma patients is between 48 ...

MANAGING OCULAR SURFACE DISEASE IN GLAUCOMA PATIENTS

If the patient has significant lid disease, warm soaks and lid scrubs can help. You may also wish to consider artificial tears. If you think there is an element ...

Glaucoma and ocular surface - Indian Journal of Ophthalmology

The most commonly used anti-glaucoma medications, timolol and latanoprost, on long-term instillation result in chronic ocular surface disease with timolol- ...

Full article: Ocular Surface Disease in Glaucoma Patients

As mentioned, ocular surface disease and glaucoma independently increase with advanced age but also occur concomitantly.Citation,Citation Higher severity of ...

Evaluation of ocular surface disease in elderly patients with glaucoma

To evaluate the symptoms and signs of ocular surface disease (OSD) and tear-film matrix metalloproteinase-9 (MMP-9) overexpression using ...

Impact of Ocular Surface Disease Treatment in Patients with Glaucoma

Short-term OSD treatment may improve ocular surface disease and IOP control, with no need to discontinue glaucoma medications.

A narrative review of ocular surface disease considerations in the ...

OSD prevalence has also been shown to correlate with glaucoma severity; Ocular Surface Disease Index (OSDI) scores tend to worsen in patients with higher drop ...

A Narrative Review of Ocular Surface Disease Related to Anti ...

However, most patients with glaucoma require long-term or lifelong use of eye drops, which is associated with ocular surface diseases (OSD) ...

How Ocular Surface Disease Impacts the Glaucoma Treatment ...

Topically treated glaucoma patients with OSD recorded lower quality-of-life scores versus patients without surface damage.

Treatment of Severe Ocular Surface Disease in the Glaucoma Patient

Ocular surface disease may be improved in eyes where glaucoma drops are stopped after successful trabeculectomy. This evidence highlights the ...

Ocular Surface Disease Exacerbated Glaucoma - Lippincott

The term we postulate is “OSD exacerbated glaucoma.” This is the first study to suggest that the use of a combination approach comprising medical treatment to ...

Ocular surface disease signs and symptoms of glaucoma patients ...

Glaucoma is associated with ocular surface disease (OSD). They both are known co-morbidities in ageing populations, and several studies have investigated the ...

Managing Ocular Surface Disease in Glaucoma Treatment - MDPI

Ocular surface disease (OSD) is a frequent disabling challenge among patients with glaucoma who use benzalkonium chloride (BAK)-containing topical glaucoma ...

Ocular Surface Disease and Glaucoma: How to Evaluate Impact on ...

The use of fixed combinations to reduce surface exposition and of benzalkonium chloride-free formulations should be encouraged to reduce and contain the onset ...

The Ocular Surface in Medically Controlled Glaucoma - IOVS

A frequently reported side effect of long-term antiglaucoma topical treatment, occurring in up to 59% of patients,5–8 is ocular surface disease. This is a ...